Posted April 2, 2016

Propell Platinum Contains Undeclared Drugs

On March 29, 2016, the FDA warned consumers not to buy or use the weight loss supplement Propell Platinum because it was found to contain undeclared sibutramine and phenolphthalein.

Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.

Phenolphthalein, once an ingredient in some over-the-counter laxative products, was reclassified by the FDA in 1999 as "not generally recognized as safe and effective."  

Propell Platinum was sold on the website www.zxtbeepollenpills.com, and possibly in some retail stores. 

Consumers who have purchased this supplement should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.

See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.

See Related Warnings:

Weight Loss Supplement Envy BP Contains Undeclared Drug

FDA Warns of Weight Supplements Containing Undeclared Drugs

Four Weight Loss Supplements Found To Contain Drugs

Weight Supplement Recalled

Five Weight Loss Supplements Recalled

Weight Loss Supplement Contains Hidden Drug